Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Brian Savage

General Counsel at Teva Pharmaceutical Industries Ltd (TEVA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $449K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 22SEC TEVATeva Pharmaceutical Industries Ltd Sell 4,50311,339 held (−28%) $38.69 $174K +6.2%
Sep 22SEC TEVATeva Pharmaceutical Industries Ltd Sell 2,5258,814 held (−22%) $39.15 $99K +5.0%
Sep 22SEC TEVATeva Pharmaceutical Industries Ltd Sell 3148,500 held (−4%) $38.70 $12K +6.2%
Mar 9SEC TEVATeva Pharmaceutical Industries Ltd Sell 1,12710,914 held (−9%) $31.67 $36K +29.8%
Mar 6SEC TEVATeva Pharmaceutical Industries Ltd Sell 1,4896,181 held (−19%) $32.46 $48K +26.6%
Mar 6SEC TEVATeva Pharmaceutical Industries Ltd Sell 1,1868,461 held (−12%) $32.46 $38K +26.6%
Mar 5SEC TEVATeva Pharmaceutical Industries Ltd Sell 1,2742,926 held (−30%) $32.36 $41K +27.0%
  • Sell

    General Counsel Brian Savage sold $174K of TEVA at $38.69 — cuts the stake by 28%.

  • Sell

    General Counsel Brian Savage sold $41K of TEVA at $32.36 — cuts the stake by 30%.